SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-066144
Filing Date
2024-05-29
Accepted
2024-05-29 19:07:46
Documents
2
Period of Report
2024-05-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6565
2 EX-24 virx-ex24.htm EX-24 11587
  Complete submission text file 0000950170-24-066144.txt   19803
Mailing Address 4401 WILSHIRE BLVD. SUITE 200 LOS ANGELES CA 90010
Business Address
ROYSTON IVOR (Reporting) CIK: 0001026765 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 241000278

Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)